By Adam L. Cataldo Annovis Bio, a clinical-stage drug platform company based in Berwyn, Pa., recently announced positive findings from an independent statistical group regarding its Phase 2/3 study on Alzheimer's disease. The company revealed that there is no need to include additional patients, allowing the study to continue as planned. Market Reaction and Future … [Read more...] about Promising Results for Annovis Bio’s Phase 2/3 Study on Alzheimer’s Disease
Inflation Woes for Senior Citizens
The latest inflation figures from the United States government are cause for concern, particularly for senior citizens. Social Security beneficiaries will only receive a 3.2% cost-of-living adjustment to their monthly checks starting in January, according to the program's administrators. This means that retired workers, who receive an average monthly check of $1,840, will only … [Read more...] about Inflation Woes for Senior Citizens
Tempest Therapeutics Stock Drops Over 50% After Rapid Surge
Shares of microcap oncology company Tempest Therapeutics Inc. (TPST) plunged more than 50% on Thursday, following a remarkable 40-fold gain in the previous day. The surge in trading prompted a temporary halt due to volatility. This significant increase in stock value was triggered by the release of new study results for Tempest's investigational treatment, TPST-1120, for liver … [Read more...] about Tempest Therapeutics Stock Drops Over 50% After Rapid Surge
Block Inc. Stock Could Double, Says Analyst
Investors might be missing out on some potential positive catalysts for Block Inc. shares, according to Barclays analyst Ramsey El-Assal. He believes that the market is too focused on the pressure in Block's seller business, overlooking the profit opportunities in the overall business. El-Assal suggests that the lack of GAAP profitability has made Block less appealing to … [Read more...] about Block Inc. Stock Could Double, Says Analyst
Assets under Management Decline for Premier Miton Group
Premier Miton Group has reported a decrease in assets under management (AUM) during the fourth quarter of fiscal 2023. Investors have shown reluctance, particularly in the U.K. and European sectors, resulting in this decline. As of September 30, the London-listed asset manager's AUM fell to £9.8 billion ($11.93 billion) from £10.5 billion at the end of June. The company … [Read more...] about Assets under Management Decline for Premier Miton Group
